$PHIO
Phio Pharmaceuticals Corp. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$1.02
▲+0.00%+$0.000
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonatePhio Pharmaceuticals Corp. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is PHIO up today? It is at $1.02 (+0.00%), and our scanner flagged it 2 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment PHIO spikes, and full due diligence on PHIO — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $PHIO 2 times in the last 30 days. Create a free account to track $PHIO, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on PHIO from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PHIO today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing4Insider trade (Form 4)Sep 16, 2026 · 3 days agoA share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Bradford Patricia A Director | Bought (open market) | +12K 0.1% of company | added 26% | 58K | $12K at $1.03 | Sep 15, 26 |
Carson Lisa Cabott Officer | Sold (automatic/other) | -13K 0.1% of company | sold 14% | 81K | $13K at $1.03 | Sep 11, 26 |
Bitterman Robert J Officer | Sold (automatic/other) | -69K 0.6% of company | sold 16% | 363K | $71K at $1.03 | Sep 11, 26 |
Plott Ronald Todd Director | Bought (open market) | +15K 0.1% of company | n/a | 15K | $17K at $1.14 | Aug 19, 26 |
Bitterman Robert J Officer | Bought (open market) | +10K 0.09% of company | added 2.4% | 431K | $11K at $1.06 | Aug 18, 26 |
Bitterman Robert J Officer | Bought (open market) | +10K 0.09% of company | added 2.4% | 421K | $10K at $0.990 | Jun 26, 26 |
Bitterman Robert J Officer | Acquired (grant/award) | +120K 1.0% of company | added 41% | 411K | n/a | Feb 5, 26 |
Bradford Patricia A Director | Acquired (grant/award) | +19K 0.2% of company | added 68% | 46K | n/a | Feb 5, 26 |
Carson Lisa Cabott Officer | Acquired (grant/award) | +47K 0.4% of company | added 100% | 94K | n/a | Feb 5, 26 |
Deming David H Director | Acquired (grant/award) | +24K 0.2% of company | added 100% | 38K | n/a | Feb 5, 26 |
Freeman Jonathan E Director | Acquired (grant/award) | +17K 0.1% of company | added 100% | 33K | n/a | Feb 5, 26 |
Lockshin Curtis Director | Acquired (grant/award) | +17K 0.1% of company | added 89% | 35K | n/a | Feb 5, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on PHIO from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PHIO today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
PHIO last traded at $1.02, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Phio Pharmaceuticals Corp. Common Stock (PHIO) is next expected to report earnings on Thursday, November 12, 2026, about 53 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The PHIO Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PHIO 2 times in the last 30 days.
PHIO (Phio Pharmaceuticals Corp. Common Stock) trades on XNAS, with a market cap of about $12M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PHIO for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$PHIO discussion
Sign in to ask a question or join the discussion.